You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美康生物(300439.SZ):控股子公司取得醫療器械註冊證
格隆匯 01-28 19:19

格隆匯 1 月 28日丨美康生物(300439.SZ)公佈,公司控股子公司江西美康盛德生物科技有限公司(“江西美康”)、澳瑞(江西)科技有限公司(“江西澳瑞”),於近日分別取得了由江西省藥品監督管理局頒發的《中華人民共和國醫療器械註冊證(體外診斷試劑)》、《中華人民共和國醫療器械註冊證》

產品涉及D-二聚體檢測試劑(熒光免疫層析法),全自動尿液有形成分分析儀,便攜式尿液分析儀,全自動尿液幹化學分析儀。

控股子公司上述《註冊證》的取得,進一步豐富和完善了公司產品的種類,更好地滿足了市場多元化的需求,有利於提高公司的核心競爭力和市場拓展能力,對公司未來的經營將產生積極影響。上述產品實際銷售情況取決於未來市場推廣效果,公司目前尚無法預測其對公司未來業績的影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account